Immediate skin-to-skin care for preterm infants after birth
This study tests if giving preterm babies skin-to-skin contact with their mothers right after birth helps improve their health and development compared to waiting 24 hours.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 0 Minutes to 30 Minutes |
| Sex | All |
| Sponsor | Medical University of Graz Academic / other |
| Locations | 1 site (Graz, Styria) |
| Trial ID | NCT06794164 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility, safety, and effects of immediate skin-to-skin contact for preterm infants born between 26 and 32 weeks of gestation. The intervention involves providing skin-to-skin care right after birth, compared to standard care which allows for contact within 24 hours. The aim is to determine the benefits of this early contact for both the infants and their mothers. The study will assess various outcomes related to the health and development of the preterm neonates.
Who should consider this trial
Good fit: Ideal candidates are preterm infants born between 26 and 32 weeks of gestation whose parents can provide informed consent.
Not a fit: Patients who are not intended for full life support or have severe congenital malformations may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the health outcomes of preterm infants and improve maternal bonding.
How similar studies have performed: Previous studies have shown positive outcomes with skin-to-skin care in preterm infants, suggesting this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gestational age between 26+0 and 32+0 weeks * Written parental informed consent Exclusion Criteria: * No intention of full life support * Severe congenital malformation
Where this trial is running
Graz, Styria
- Medical University of Graz — Graz, Styria, Austria (Recruiting)
Study contacts
- Study coordinator: Nariae Baik-Schneditz, MD, PhD
- Email: nariae.baik@medunigraz.at
- Phone: +4331638582677
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.